Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I can’t tell you how many times you have mentioned you sold over the years. C’mon man keep it real.
You had no idea
Again reading not your strong suit, I get it. He did say, and it’s not in the filings, that they have 12 months of funding. Kind of important.
I’m not concerned. You may be, but I’m not. I wish they were more transparent but these companies are very secretive, usually for good reason. My guess is our next big move up corresponds to events around AGM when they name new board of director, maybe actually show the robot, and perhaps hit another milestone and infusion of another tranche from Medtronic.
Also I imagine the camera patents are as big as any. 2-D exploratory camera can be adapted for any robotic arm and it appears Titan is the only company that can offer it. Look at the drawings and claims/description of the 3D High def camera. Amazing what this can do and it looks like the camera will have similar degrees of freedom as the robotic arms. Advanced visualization will be of the utmost importance with machine learning/data analytics/AR/VR etc. Perhaps this will greatly enhance what Medtronics acquisition of Digital Surgery is able to do.
To your point it looks like this is “robotics technologies” company now. That is the reason for the rebrand. They are more than a single port robot company. The new access device patent shows this to be the case as it can be adapted for different tools and laproscopic tech as well.
Quarter of a billion dollars sounds awfully cheap to me to build a surgical robot. That is amazing that they were able to pull that off for anything under 1/2 a billion. Thanks for pointing that out Sport. Just another reason for me to load up if this drops again.
That wasn’t the bottom. .13 was. You bought at double the bottom. This stuff writes itself
Honey- I am wrong. Thank you for taking the time to explain that. Very interesting stuff. And yes, us shareholders need to open our eyes because someone owns a large chunk of Titan. I think this is good but it would be great to know for sure. I agree with you in that it is probably a healthcare mutual fund acting on behalf of Medtronic. Today is the 10th so my eyes will be peeled to see if it’s disclosed in Edgar today otherwise we may not get it until 45 days after EOY. Whoever it is will still surely sell off some of it to stay under 20 % ownership as my understanding is that would have to be voted on.
No one owns 13 million commons. How do you figure? There is only 66.43 million common. That 78 number floated around was a mistake. It included the prefunded warrants which have not been exercised yet.
Good stuff Roll. This kind of stuff happens all the time. If I had to guess, which I am, I bet something like this occurred with our last offering. Would love to see new milestones, vote proposals for the AGM(director, ownership >20%. Maybe? etc), AGM announcement(shouldn’t that be imminent), 13G statement of ownership, videos/pics of the actual robot. Aren’t we a little too far into this to keep accepting CAD drawings and simulated videos? Did any of you guys check out the 3 new patents on Espacenet? Titan has been some busy bees. The new access device is pretty awesome to the amateur eye. Looks like it can be adapted to a bunch of different uses? Robotic(single, multi, other) and laproscopic. To that point, wouldn’t a device like this require 510k clearance? Aren’t these big business in their own right? I wonder what type of value these 3 patents add....
I’m still waiting for his due diligence on how he knows Medtronic did not buy this last offering. Nothing....
Well said!
And btw I have no idea if it’s Medtronic or not either. I can infer that it may be based on some things but I can’t say for sure. Reality is no one knows except for Titan and their Investor/s
Medtronic is one of the biggest institutional healthcare investors. Again, no idea if it’s Medtronic or not. Prove it
First go to the dictionary and look up the definition of licensing and then look up the definition of development and then read the licensing and development agreement. Hint: it’s for development of joint intellectual property for a project that isn’t SPORT in the form of Royalty payments to Titan. Now I’m not gonna do your DD for you anymore. Go get your shine box kid.
Bueller....Bueller....Bueller
How do you know they didn’t take an equity position? What is your source?
Guess you didn’t read the full agreement . Par for the course with you. It has nothing to do with the licensing. It’s for the development.
That is for IP created during joint development agreement. That is not for the IP that Titan licensed to Medtronic.
Hahaha. The Amazon Driver. I know what you mean same guys after my wife too
Amen to that!
Yawn.
Since you seem to do very little dd he is with another prominent Robotics company that he could conceivably be there to do the same thing he did with Titan.
HC - we are already at 78.83 million shares
https://www.bloomberg.com/quote/TMDI:US
Thank you! I will say no need to be secretive about the COEs. They know who they are. They were knocking on the door of IDE submission (meaning) it was the next step. Within a month they were lined up for human trials. I’m guessing there may be some delays on this for a couple of reasons. They are installing software. Which, now that we know about medtronic, did they pivot and are they now using Medtronics software? Also, I imagine IRBs may be delayed at hospitals because of covid and i imagine it’s difficult to recruit benign hysterectomies that fit their criteria for these trials because of Covid. I’m guessing they are pretty close to submitting for CE and may not need human trials. It will be interesting to see if them move this forward.
Ok why would they do that?
Looking forward. This is the list of things I am anxiously awaiting: who bought the offering?(will we find out), board member(May tell a lot about who bought the offering), AGM meeting announcement, items to be voted on at AGM(Board Members, ownership above 20%?, compensation, option issuance), SEEING the robot(if the patent pictures are any indications this robot should look a lot different than when we have last seen it). Yes we’ve seen cad drawings and simulation videos but I’d like to see the real McCoy. This is long past due in my estimation. Speaking of long past due, anxiously awaiting an updated milestone chart for both development of SPORT timeline and more detailed milestone chart for the development agreement with Medtronic. Announce of COEs that human trials will be done at? ENOS - really want to hear plan and timeline for rebranding? New website- when is that being delivered. What else am I missing?
They already announced c’mon keep up. Read. What do you think the milestone payments are for?
78 million os. Only 6.5 million from that offering hit the float rest were prefunded warrants. Who is exercising? Do you think another raise is coming? Looks to me they may fund this the rest of the way with warrants.
78 million os HC. Someone’s been exercising above and beyond Armistice.
Please see the link for information on Medtronics Hugo platform. Thanks for your DD.
https://www.massdevice.com/medtronic-finally-unveils-its-new-robot-assisted-surgery-system/
That happened quite a bit when you think back. I thought it was a coincidence at the time. Haha
No doubt MDT will have multiport, single port and endoluminal robots. They have to.
Was I giving this board too much credit In not pointing that out?
The entity who bought the offering has to file.
This is interesting 78.83 million outstanding shares. Looks like someone is exercising warrants.
Nobody can answer that because no one knows what the plans are for Titan, the robot and Medtronic. Are they planning to commercialize? Maybe not but if so you’re gonna get a lot more dilution. Will they get bought out at FDA or sooner? Only they can answer that. It will certainly impact dilution. The only revenue they have is from licensing basically so can’t really answer that. This is a speculative investment that just got some validation. You have to answer a lot of questions based on your due diligence. Do you think this gets bought, commercialized, sold off on the cheap? Once you answer those then you might be able to put some math to it. You won’t get solid answers on here to any of those questions. No one knows. This isn’t an S&P500 company that opens up their books and tells you their story.
Wouldn’t be trending down? It’s the stock market. Just the ebbs and flows. Stop looking at it daily/hourly and look at it weekly monthly. It’s Medtronic! They(Titan)have spent 250 million dollars in public funds to build this robot. Market Cap 75-80 million. Medtronic licensing and partnering validates the value of the company. No way should it be under a 250 million market cap at this point. And probably worth significantly more because they turned that money into valuable IP that will lead to further licensing, partnering, and possibly acquisition in a large addressable market with huge barriers to entry. What’s not to like?
Nobody bought the 18 million shares. They didn’t buy all shares mostly warrants